🇺🇸 FDA
Patent

US 10239830

Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disorders

granted A61KA61K31/165A61K31/4164

Quick answer

US patent 10239830 (Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disorders) held by The United States of America, as represented by the Secretary, Depart. of Health and Human Services expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Depart. of Health and Human Services
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/165, A61K31/4164, A61K31/44, A61P